BNOEF Stock: Bionomics Limited Stock Price, Analysis & Insights
Get live BNOEF stock price $0.01, comprehensive Bionomics Limited stock analysis, charts, news, and expert forecast. Real-time BNOEF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Bionomics Limited, an Australian clinical-stage biopharmaceutical company founded in 1996 and based in Eastwood, focuses on identifying and developing innovative drug candidates to address central nervous system conditions and various cancers. A sign...
Company Information
- CEO
- Spyridon Papapetropoulos
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- N/A
Contact Information
- Website
- https://www.bionomics.com.au
- Address
- 200 Greenhill Road
- Country
- AU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.84)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bionomics Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bionomics Limited
- ⚠Investors should consider how Bionomics Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
8.81M
P/E Ratio (TTM)
-0.60
Beta
1.84
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BNOEF with peer companies:
- Price
- $8.50
- Market cap
- 12.59M
- Price
- $0.00
- Market cap
- 4.26K
- Price
- $300.00
- Market cap
- 7.45M
- Price
- $0.50
- Market cap
- 8.44M
- Price
- $0.09
- Market cap
- 7.78M
- Price
- $0.03
- Market cap
- 1.14M
- Price
- $0.25
- Market cap
- 8.65M
- Price
- $1.99
- Market cap
- 6.82M
- Price
- $0.26
- Market cap
- 15.88M
- Price
- $0.00
- Market cap
- 7.87M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.